NCT03760874

Atrial Fibrillation Research Database

Prospective Register Study to Record Safety and Efficacy of Oral Anticoagulants in Atrial Fibrillation Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 5,000 (estimated)
• Sponsor: University of Campania Luigi Vanvitelli · Academic / Other
• Sex: All
• Age: 18 Years – 110 Years
• Healthy volunteers: Not accepted

Summary

All patients with atrial fibrillation who are treated with vitamin-k antagonists (warfarin, phenprocoumon) or non vitamin K oral anticoagulants (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in real world settings will be recorded in this register. Within this register a characterization of patients and therapy (with regard to medication, dose and duration) will be done. On basis of defined clinical relevant end points the long-term efficacy and safety will be evaluated.

Conditions

• Anticoagulants and Bleeding Disorders
• Atrial Fibrillation

Timeline

• Start date: 2013-06-13
• Primary completion: 2022-01-01
• Completion: 2023-01-01
• First posted: 2018-11-30
• Last updated: 2020-06-11

Locations

1 site across 1 country: Italy